Azurity Pharmaceuticals Announces the Availability of JAVADIN™ (clonidine hydrochloride) Oral Solution

Approved, Ready-to-Use Clonidine Oral Solution for Hypertension Control in Adult PatientsWoburn, MA, Dec. 18, 2025 (GLOBE ...
Medscape

Clonidine as a First-line Sedative Agent After Neonatal Cardiac Surgery

Objectives: To determine the cardiovascular tolerance of clonidine used as a first-line sedative after cardiac surgery in small infants. Design: Retrospective chart review. Setting: A tertiary and ...
Business Wire

Tris Pharma Receives U.S. FDA Approval for Once-Daily ONYDA XR (clonidine hydrochloride) Extended-Release Oral Suspension, the First-and-Only Liquid Non-Stimulant ADHD Medication

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
WLKY

Warning: Pharmacy in Henry County may have gotten bad shipment of clonidine

Health officials put out a warning Monday, saying multiple people in Henry County got sick connected to prescribed clonidine."If your child has been prescribed clonidine oral suspension and it was ...

Azurity Pharmaceuticals Announces the Availability of JAVADIN(TM) (clonidine hydrochloride) Oral Solution

Javadin is a berry-flavored, clear, colorless oral solution. Each 5 mL delivers 0.1 mg of clonidine (0.02 mg/mL). Javadin may be used alone or in combination with other antihypertensive agents.